Loading...
research article
Development of organometallic ruthenium(II) anticancer (RAPTA) drugs
2007
A review. The systematic development of the RAPTA family of organometallic ruthenium(II) anticancer drugs contg. a monodentate 1,3,5-triaza-7-phosphatricyclo-[3.3.1.1]decane ligand and a h6-arene ligand is described.
Type
research article
Web of Science ID
WOS:000246401500005
Authors
Publication date
2007
Published in
Volume
61
Issue
4
Start page
140
End page
142
Peer reviewed
REVIEWED
EPFL units
Available on Infoscience
March 9, 2008
Use this identifier to reference this record